Permeability of 5-fluorouracil and prodrugs in Caco-2 cell monolayers

International Journal of Pharmaceutics

Volumn 129, Issue 1-2, 1996, Pages 223-231

  Buur, Anders ^a,c   Trier, Lars ^a   Magnusson, Christin ^b   Artursson, Per ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UPPSALA UNIVERSITY   (Sweden)

^c H LUNDBECK A S   (Denmark)

Author keywords

5 Fluorouracil; Caco 2 monolayers; Drug absorption; Permeability; Prodrugs; Toxicity

Indexed keywords

FLUOROURACIL; FLUOROURACIL DERIVATIVE; PRODRUG;

ARTICLE; CELL CULTURE; COLON ADENOCARCINOMA; DRUG HYDROLYSIS; DRUG SOLUBILITY; DRUG TRANSPORT; HUMAN; HUMAN CELL; IONIZATION; MOLECULAR WEIGHT; PARTITION COEFFICIENT; PRIORITY JOURNAL; REGRESSION ANALYSIS; SKIN PENETRATION; SKIN PERMEABILITY;

EID: 0029872476     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5173(95)04331-4     Document Type: Article

References (28)

1. Almersjö, E.E., Gustavsson, B.G., Regårdh, C.-G. and Wålen, P., Pharmacokinetic studies of 5-fluorouracil after oral and intravenous administration in man. Acta Pharmacol. Toxicol., 46 (1980) 326-336.
2. Amidon, G.L., Yalkowsky, S.H., Anik, S.T. and Valvani, S.C., Solubility of nonelectrolytes in polar solvents. V. Estimation of the solubility of aliphatic monofunctional compounds in water using a molecular surface area approach. J. Phys. Chem., 79 (1975) 2239-2246.
3. Anderberg, E.K., Nyström, C. and Artursson, P., Epithelial transport of drugs in cell culture, VII. Effects of pharmaceutical surfactant excipients and bile acids on transepithelial permeability in monolayers of human intestinal epithelial (Caco-2) cell., J. Pharm. Sci., 81 (1992) 879-887.
4. Artursson, P., Epithelial transport of drugs in cell culture. I. A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells. J. Pharm. Sci., 79 (1990) 476-482.
5. Artursson, P. and Karlsson, J., Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem. Biophys. Res. Commun., 175 (1991) 880-885.
6. Artursson, P., Ungell, A.-L. and Löfroth, J.-E., Selective paracellular permeability in two models of intestinal absorption: cultured monolayers of human intestinal epithelial cells and rat intestinal segments. Pharm. Res., 10 (1993) 1123-1129.
7. Buur, A. and Bundgaard, H., Prodrugs of 5-fluorouracil. I. Hydrolysis kinetics and physicochemical properties of various N-acyl derivatives of 5-fluorouracil. Int. J. Pharm., 21 (1984) 349-364.
8. Buur, A., Bundgaard, H. and Falch, E., Prodrugs of 5-fluorouracil. IV. Hydrolysis kinetics, bioactivation and physiochemical properties of various N-acyloxymethyl derivatives of 5-fluorouracil. Int. J. Pharm., 24 (1985) 43-60.
9. Buur, A. and Bundgaard, H., Prodrugs of 5-fluorouracil. V. 1-Alkoxycarbonyl derivatives as potential prodrug forms for improved rectal or oral delivery of 5-fluorouracil. J. Pharm. Sci., 75 (1986a) 522-527.
10. Buur, A. and Bundgaard, H., Prodrugs of 5-fluorouracil. VI. Hydrolysis kinetics and bioactivation of 3-nicotinoyl-5-fluorouracil and various 1-substituted derivatives of 3-benzoyl-5-fluorouracil. Arch. Pharm. Chem. Sci. Ed., 14 (1986b) 99-112.
11. Buur, A. and Bundgaard, H., Prodrugs of 5-fluorouracil. VIII. Improved rectal and oral delivery of 5-fluorouracil via various prodrugs. Structure-rectal absorption relationships. Int. J. Pharm., 75 (1986c) 676-679.
12. Buur, A., Yamamoto, A. and Lee, V.H.L., Penetration of 5-fluorouracil and prodrugs across the intestine of the albino rabbit: evidence for shift in absorption site from the upper to the lower region of the gastrointestinal tract by prodrugs. J. Controlled Release, 14 (1990) 43-51.
13. Christophidis, N., Vajda, F.J.E., Lucas, I., Drummer, O., Moon, W.J. and Louis, W.J., Fluorouracil therapy in patients: a pharmacokinetic comparison of various rates and routes of administration. Clin. Pharmacokinet., 3 (1978) 330-336.
14. Cohen, J.L., Irwin, L.E., Marshall, G.J., Darven, H. and Bateman, J.R., Clinical pharmacology of oral and intravenous 5-fluorouracil (NSC-19893). Cancer Chemother. Rep., 58 (1974) 723-732.
15. Conradi, R.A., Hilgers, A.R., Ho, N.F.H. and Burton, P.S., The influence of peptide structure on transport across Caco-2 cells. Pharm. Res., 8 (1991) 1453-1460.
16. Hovgaard, L., Brøndsted, H., Buur, A. and Bundgaard, H., Drug delivery studies in Caco-2 monolayers. Synthesis, hydrolysis, and transport of 0-cyclopropane carboxylic acid ester prodrugs of various β-blocking agents. Pharm. Res., 12 (1995) 387-392.
17. Inui, K.-I., Yamamoto, M. and Saito, H., Transepithelial transport of oral cephalosporins by monolayers of intestinal epithelial cell line Caco-2: specific transport systems in apical and basolaterial membranes. J. Pharmacol. Exp. Ther., 261 (1992) 195-201.
18. Karlsson, J. and Artursson, P., A method for the determination of cellular permeability coefficients and aqueous boundary layer thickness in monolayers of intestinal epithelial (Caco-2) cells grown in permeable filter chambers. Int. J. Pharm., 71 (1991) 55-64.
19. Karlsson, J., Kuo, S.-M., Ziemniak, J. and Artursson, P., Transport of celiprolol across human intestinal epithelial (Caco-2) cells: mediation of secretion by multiple transporters including P-glycoprotein. Br. J. Pharmacol., 110 (1993) 1009-1016.
20. Kim, D.-C., Burton, P.S. and Borchardt, R.T., A correlation between the permeability characteristics of a series of peptides using an in vitro cell culture model (Caco-2) and those using an in situ perfused rat ileum model of the intestinal mucosa. Pharm. Res., 10 (1993) 12.
21. Lennernäs, H., Palm, K., Fagerholm, U. and Artursson, P., Comparison between active and passive drug transport in human intestinal epithelial (Caco-2) cells in vitro and human jejunum in vivo. Int. J. Pharm., (in press, 1996).
22. Lundin, S., Möss, J., Bundgaard, H. and Artursson, P., Absorption of thyrotropin-releasing hormone (TRH) and TRH prodrug in a human intestinal cell line (Caco-2). Int. J. Pharm., 76 (1991) R1-R4.
23. Palm, K., Luthman, K., Ungell, A-L., Strandlund, G. and Artursson, P., A new method for the prediction of intestinal drug absorption based on molecular surface properties. J. Pharm. Sci. (in press, 1996).
24. Rubas, W., Villagran, J., Cromwell, M., McLeod, A., Wassenberg, J. and Mrsny, R., Correlation of solute flux across Caco-2 monolayers and colonie tissue in vitro. S.T.P. Pharm. Sci., 5 (1995) 93-37.
25. Smith, P., Mirabelli, C., Fondacaro, J., Ryan, F. and Dent, J., Intestinal 5-fluorouracil absorption: use of Ussing chambers to assess transport and metabolism. Pharm. Res. 5 (1988) 598-603.
26. 1-antihistaminic agents in relation to their central sedative side-effects. Eur. J. Pharm. Sci., 2 (1994) 373-384.
27. Toth, I., Hillery, A.M., Wood, I.P., Magnusson, C. and Artursson, P., Oral absorption of lipidic amino acid conjugates. Int. J. Pharm., 102 (1994) 223-230.
28. 2 receptor histamine antagonists. J. Med. Chem., 31 (1988) 656-671.